CClinicalTrials.gg
Status unknownNCT02569580Updated Oct 7, 2015

Effectiveness of "No More" Anti-lice Medical Device to Kill Lice and Lice Eggs

An interventional study of Topically in Lice, sponsored by Pharmayeda. Status unknown at 1 site in Israel. Open to participants aged 3 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-10-07.

Sponsored by Pharmayeda · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Oct 2015), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
3 Years to 18 Years
Sex
All
01

Study summary

The purpose of this study is to determine effectiveness of an Anti-lice treatment using the medical device "No More" which is designed to kill lice and lice eggs on the head.

Read the detailed description

The Clinical Trial Protocol include 2 visits

First Visit: Explanation and signing of consent forms. Diagnosis: Prof. Shemer will check if the patients have sufficient living lice or lice eggs and if so they will be scheduled to receive treatment.

Second Visit: -Spread the "No More" on the head of the boy or girl on dry hair.

  • After five minutes comb with an adequately thick comb and the eggs will fall out easily with the pulling of the comb.
  • Wash the hair.
  • Combing the hair again with a thick comb for five minutes and/or 20 combings; Checking if the head is free of eggs and lice via a visual inspection by the head researcher.

Outcome

  1. If there are no live eggs and/or lice then the patient has completed treatment - and the research. (This outcome is defined as successful treatment.)
  2. If there are eggs only then the patient is scheduled for a third visit after seven days (+/- one day).
  3. If live lice are found this outcome is defined as failure and the patient will not be scheduled for an additional visit

Third Visit:

After seven days (+/- one day) Professor Shemer will conduct a visual inspection for lice and lice eggs. Combing with a thick comb for five minutes and/or 20 combings and if there are live lice or lice eggs

Treatment Success:

No eggs and no lice immediately with the end of the treatment (second visit). No lice or live lice eggs after seven days (+/- one day).

Number of Participants: Up to 80 participants when at least 50 participants complete the treatment.

Age Range: 3-18 years

02

Conditions studied

  • Lice

Browse trials for

Keywords

  • anti-lice treatment
03

In context

Lice Infestations

58 studies on the registry are indexed under Lice Infestations; 4 are open to participants now.

This study's planned enrollment of 50 is below the median of 118 across 56 interventional studies indexed under Lice Infestations.

Browse Lice Infestations studies →

Lead sponsor

This is the only study on the registry with Pharmayeda as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Patients that are suffering from lice and lice eggs that agree to refrain from any other treatment or salve designed for the treatment of lice and/or lice eggs throughout the course of the research study.

Patients that orally and in writing express their agreement to participate in the study - Consent in writing will be provided by two parents; Oral consent will be provided by the participants themselves.

Exclusion criteria

Exclusion Criteria:

Pregnant or nursing women.

Patients lacking the faculties for proper judgment.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Interventions

  • DeviceTopically

    use the "No More" medical device as anti lice treatment

06

What researchers measure

Primary outcomes

  1. No live lice eggs and/or live lice

    Time frame: 1 day from second visit

07

Study locations

1 of 1 sites recruiting
  • Prof. Avner Shemer clinic
    Netanya, 42150, Israel
    • Ben Berger · Contact · ben@medicly.com · 972-545679344
    • Miriyam Srur · Contact · 09-8657777
    • avner S Shemer, Prof. · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 7, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02569580
Lead sponsor
Pharmayeda
Responsible party
Sponsor
First posted
Oct 7, 2015
Start date
Oct 2015
Primary completion
Oct 2016 (estimated)
Completion
Dec 2016 (estimated)
Last update
Oct 7, 2015

Study contacts

Orna Levin, Dr
Contact
"Dr. Orna Levin" <dr.ornal@pharmayeda-ind.co.il>
972-525286000
orly simhony
Contact
orly@pharmayeda-ind.co.il
972-528747434
Ben Berger
study director · Prof. Avner Shemer clinic

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion